YY/T 1451-2016B-type natriuretic peptide and N-terminal pro—B-type natriuretic peptide test reagent(quantitative labelling immunoassay) (English PDF)
脑利钠肽和氨基末端脑利钠肽前体检测试剂(盒)(定量标记免疫分析法)
This is a limited preview
Buy now to download the full PDF (16 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1451-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
January 26, 2016
Implementation date
January 1, 2017
Scope
YY/T 1451-2016 is the English-translated version of 脑利钠肽和氨基末端脑利钠肽前体检测试剂(盒)(定量标记免疫分析法).
YY/T 1451-2016 is the Chinese pharmaceutical industry standard for the test reagent that measures B-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide by a quantitative labelled immunoassay, the markers used in heart failure.
It specifies the requirements, the test methods, the identification, the labelling, the instruction manual and the rules for packaging, transport and storage, covering the appearance, the traceability of the calibrator, the accuracy, the linear range, the detection limit, the precision, the hook effect and the stability. Issued on 26 January 2016, it has applied since 1 January 2017.
Found what you need?
Document preview — YY/T 1451-2016
National Standard of the People's Republic of China
- ICS
- 11.100
- Classification
- C 44
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- Introduction
- 1 Scope
- 2 Normative reference documents
- 3 Request
Foreword
This standard is drafted in accordance with the rules given in GB/T 1.1-2009.
Introduction
Natriuretic peptide (natriureticpeptide, NP) is nearly 20 years to find a class of sodium, diuretic endogenous peptide, to the head
So far, humans have found five kinds of natriuretic peptides, namely atrial natriuretic peptide (ANP), B-type natriuretic peptide (B-type natriuretic peptide, BNP), C-typenatriuretic peptide (CNP), V-type natriuretic peptide (ventriclelnatri-
ureticpeptide, VNP) and D-type natriuretic peptide (VNP). Japanese scholar TetsujiSudoh And so on in 1988 from the brain brain isolated BNP, which also known as brain natriuretic peptide (brainnatriureticpeptide, BNP), in fact Mainly from the heart.
BNP is a good indicator of cardiac function, it is the diagnosis of chronic congestive heart failure (heart failure) with a high degree of sensitivity, Specificity, in 2001 has been included in the European Heart Association's latest guidelines for heart failure. BNP is mainly synthesized by the ventricles, initially
Was synthesized into a prepro-BNP containing 134 amino acids, and then the N-terminal 26-amino acid signal peptide was cleaved to contain 108 amino acids
BNP, released into the blood. As NT-proBNP and BNP are equimolar release, so the two in the diagnosis of cardiovascular disease, treatment Measurement and prognosis has a similar clinical application.
BNP translation of the current on the lot, the literature is not the same. In 1989, there are scholars in China will be translated as "brain sodium
Natriuretic peptide "," type B urinary sodium excretion peptide "and" B sodium natriuretic peptide. "The same substance using a large number of translation to the clinical application of a lot of confusion And inconvenience, the urgent need for the early translation of its Chinese standard uniform. In this standard, BNP (B-typenatriureticpeptide or Brainnatriureticpeptide) B-type natriuretic peptide or brain natriuretic peptide, NT-proBNP (N-terminalpro-B-typenatriuretic peptide or Amino-terminalpro-B-typenatriuretic peptide/Brainnatriureticpeptide) Natriuretic peptide precursor or N-terminal brain natriuretic peptide precursor.
1 Scope
This standard specifies the requirements for brain natriuretic peptide and amino-terminal brain natriuretic peptide precursor test kit (quantitative labeling immunoassay) Inspection method, identification, labeling, instruction manual, packaging, transportation and storage.
This standard is applicable to reagents (cassettes) for the quantitative detection of brain natriuretic peptide (hereinafter referred to as "BNP reagent (box)"), (Hereinafter referred to as "NT-proBNP detection reagent (cassette)") for quantitative detection of sodium peptidoglysin. This standard does not apply to.
a) various types of colloidal gold marking test paper;
b) Various radioimmunoassay or immunoassay kits labeled with radioisotope such as 125I.
2 Normative reference documents
The following documents are indispensable for the application of this document. For dated references, only the dated edition applies to this document. For undated references, the latest edition (including all modifications) applies to this document.
GB/T 191 packaging and storage icon
GB/T 21415-2008 In Vitro Diagnostic Medical Devices Quantitative Measurement of Biological Samples Metering of Calibration and Control Substance The origin of traceability
YY/T 0466.1 Symbols for medical devices for labeling, labeling and providing information on medical devices - Part 1. General requirements
3 Request
3.1 Appearance
Should be based on the characteristics of the product packaging to specify the appropriate appearance requirements. Generally should be the composition of the components of the kit, traits, inner and outer packaging, labels And so on.
a) kit components should be complete, both inside and outside the packaging should be complete, clear label;
b) liquid reagents no leakage, freeze-dried components were loose body, after the liquid solution evenly (no visible particles, no precipitation).
3.2 Traceability
Should be based on GB/T 21415-2008 and the relevant provisions of the use of BNP, NT-proBNP calibrator source, the assignment process and Measurement uncertainty and so on.
3.3 Accuracy
Accuracy should meet one of the following requirements. a) Relative deviation.
A test reference substance (CRM) or other recognized reference substance that can be used to evaluate a conventional method is used as a sample for its measurement The relative deviation of the results should not exceed ± 10%.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 16 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 191Graphical symbols marking for handling and storage of packages
- GB/T 21415-2008In vitro diagnostic medical devices - Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples
- YY/T 0466.1Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements
Similar standards
How to Download YY/T 1451-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Fast delivery
After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 191-2000 — Packaging-Pictorial marking for handling of goods
GB/T 191-2008 — Packaging - Pictorial marking for handling of goods
GB/T 191-2025 — Graphical symbols marking for handling and storage of packages
YY/T 1451-2016
$149.00